ÌÇÐÄ´«Ã½

Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

VIDO-InterVac on new federal funding, vaccine trial

VIDO-InterVac Director and CEO Dr. Volker Gerdts joins ÌÇÐÄ´«Ã½ Morning to discuss where $59 million in federal funding will go to, along with an update on their vaccine trial.

Advertisement

More Videos

Advertisement

You are viewing an .

View Original Article